2019 American Transplant Congress
The Burden of Recipient Driving Distance and Post Lung Transplant Outcomes: A National Cohort Study
Cleveland Clinic, Cleveland, OH
*Purpose: There are only 75 lung transplant centers in the United States, which leads to a spectrum of travel burdens among patients in order to…2019 American Transplant Congress
Lung Transplant Outcomes after CABG
*Purpose: Prior coronary artery bypass grafting (CABG) has been a contraindication to lung transplantation (LTx) due to increased mortality associated with bilateral lung transplant. We…2019 American Transplant Congress
Outcomes of Adult Lung Transplant Recipients of Donation after Circulatory Death Allografts in the US
*Purpose: This analysis was performed to compare outcomes of adult lung (LU) transplant (TX) recipients of donation after circulatory death (DCD) and donation after brain…2019 American Transplant Congress
The Impact of Removing DSA as a First Unit of Lung Allocation: Preliminary Results
*Purpose: In an emergency action on November 24, 2017 the Organ Procurement and Transplantation Network (OPTN) altered US lung allocation policy by replacing the donor…2019 American Transplant Congress
Organ Donation Survey among Health Care Professionals in Argentina
*Purpose: Our objective was to survey health care professionals (HCPs) responsible for the care of potential organ donors (PODs) on attitude toward organ donation, knowledge…2019 American Transplant Congress
Success in Lung Transplantation Outcomes after Receiving a Standardized Desensitization Therapy
*Purpose: With a goal to develop a safe, effective, and consistent approach to desensitization therapy using IVIg in lung transplant (LuT), we instituted a standard…2019 American Transplant Congress
Flow Cytometric Analysis of Leukocyte Migration during Ex Vivo Lung Perfusion with CXCR4 Inhibition
1General Surgery, Duke University, Durham, NC, 2Thoracic Surgery, Duke University, Durham, NC
*Purpose: Ex vivo lung perfusion (EVLP) has emerged as a preservation technique utilized to evaluate candidate donor lungs in a metabolically active state. This also…2019 American Transplant Congress
Treatment of Pseudomonas Infection with Beta-Lactams Including Ceftolozane-Tazobactam in Solid Organ Transplant Recipients
*Purpose: Ceftolozane/Tazobactam (CT) is a potent anti-pseudomonal agent with broad gram-negative activity. Our academic medical center recommends the use of CT for patients with a…2018 American Transplant Congress
Survival Rates of Patients with Previous Cardiac Surgery Undergoing Lung Transplant
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH.
Background: Severe heart diseases are traditionally considered a contraindication for Lung transplantation (LTx). There are suggestions that patients with severe heart diseases undergoing LTx will…2018 American Transplant Congress
Prospective Trial Using Pulmonary Rehabilitation to Treat Frailty
Background: Frailty is a novel risk factor to potential lung transplant candidates and recipients associated with excess morbidity and mortality. Limited data is available on…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- Next Page »